FINWIRES · TerminalLIVE
FINWIRES

Cynata Therapeutics Says Results for Phase Three Drug Candidate Study for Knee Osteoarthritis Expected in June; Shares Rise 6%

By

Cynata Therapeutics (ASX:CYP) said the results for the Australian phase three SCUlpTOR trial of its CYP-004 drug candidate in patients with osteoarthritis of the knee are expected in June, according to a Wednesday Australian bourse filing.

The trial enrolled a total of 321 patients, who were randomized to receive either CYP-004 or placebo, with co-primary endpoints assessing change in pain and cartilage thickness, the filing said. The study database was locked, and the process of data analysis is ongoing.

The results for the company's phase two trial of its CYP-001 drug candidate in adults with acute graft versus host disease are anticipated in late June or early July.

A total of 65 participants were enrolled across clinical centers in Australia, the US, and Europe, randomized to receive either steroids plus CYP-001 or steroids plus placebo. The primary endpoint is overall response rate at Day 28.

The company's shares rose nearly 6% in recent trading on Wednesday.

Related Articles

Asia

American Rare Earths Begins Wyoming Mine Exploration Drilling Program, Shares Jump 5%

American Rare Earths (ASX:ARR) began its exploration drilling program at the Cowboy State mine within the Halleck Creek rare earths project in Wyoming, according to a Wednesday Australian bourse filing.It engaged Boart Longyear to drill up to around 3,050 meters across 19 holes on Red Mountain at the mine. The program is designed to provide the geological and geotechnical foundation for a definitive feasibility study.Drilling started on May 13 and is scheduled to end by mid-July.Its shares climbed 5% in recent trading on Wednesday.

ASX:ARR
Asia

Amaero Initiates Dust Hazard, Engineering Review of Tennessee Manufacturing Facility

Amaero International (ASX:3DA) initiated a dust hazard and engineering review of its manufacturing facility in Tennessee after a small contained fire occurred during planned remediation work on Tuesday, according to a Wednesday Australian bourse filing.It expects to pause titanium powder production for around four to six weeks while it completes the review and makes any recommended remediation.No injuries were sustained, and there was no damage to the building or capital equipment. The fire was extinguished immediately, it added.It engaged a contractor to undertake the removal of sections of the exhaust system that contained PVC piping, to be replaced with stainless steel, and a small fire occurred during the removal work.Its shares fell 2% in recent trading on Wednesday.

ASX:3DA
Asia

Market Chatter: Samsung Electronics to Build First Vietnam Chip Testing Plant; Shares Jump 7%

Samsung Electronics (KRX:005930) plans to invest $1.5 billion in Vietnam to build its first chip testing factory in the country, The Economic Times reported Wednesday, referring to a company document reviewed by Reuters.Construction has already begun at an industrial park about 60 kilometers north of the Vietnamese capital of Hanoi, with operations expected to start in November 2027, the report said.Shares of Samsung Electronics fell nearly 7% in recent trade.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

KRX:005930